APA (7th ed.) Citation

W, K., P, C., AA, R., E, L., E, D., W, S., . . . LC, R. (2022). Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer. Frontiers in oncology, 12, 1010311. https://doi.org/10.3389/fonc.2022.1010311

Chicago Style (17th ed.) Citation

W, Kian, et al. "Real-world Efficacy and Safety of Mobocertinib in EGFR Exon 20 Insertion-mutated Lung Cancer." Frontiers in Oncology 12 (2022): 1010311. https://doi.org/10.3389/fonc.2022.1010311.

MLA (9th ed.) Citation

W, Kian, et al. "Real-world Efficacy and Safety of Mobocertinib in EGFR Exon 20 Insertion-mutated Lung Cancer." Frontiers in Oncology, vol. 12, 2022, p. 1010311, https://doi.org/10.3389/fonc.2022.1010311.